# Astrazeneca (AZN): value investors who own it | moatshark

4 value investors held Astrazeneca in their Q3 2026 13F, led by Troy Asset Management, Polen Capital Management, Dodge & Cox, Horizon Kinetics.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Troy Asset Management | 0.2% | $7.4m | New | 1 |
| Polen Capital Management | 0.0% | $3.5m | Trimmed -28% | 2 |
| Dodge & Cox | 0.0% | $10.6m | Trimmed -2.7% | 2 |
| Horizon Kinetics | 0.0% | $951k | Trimmed -4.6% | 2 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-08-08 | Sharma Mani | See Remarks | Bought | 20.233 | $3k |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/azn). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.